SILVER SPRING, Md., June 29, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today continued to take action in the ongoing response to the COVID-19 pandemic:
The FDA and the Federal Trade Commission (FTC) jointly issued a warning letter to Hong Kong-based SuperHealthGuard and Loyal Great International, Ltd., advising these companies to cease selling unapproved products online to customers in the United States with misleading claims that such products mitigate, prevent, treat, diagnose, or cure COVID-19 in people. The FDA's action is in support of its efforts to protect the public health. FTC's action enforces provisions of the FTC Act, 15 U.S.C. 41, prohibiting unsupported drug advertising claims. There are no drugs approved by the FDA to prevent or cure COVID-19 in people. FDA advised the companies to review their respective websites to ensure that they are not misleadingly representing unproven products as safe and effective for a COVID-19-related use. Failure to immediately correct the unapproved new drug and misbranding violations could result in legal action, including, without limitation, seizure and injunction. FDA is advising consumers not to purchase or use certain products that have not been approved, cleared, or authorized by FDA and that are being misleadingly represented as safe and/or effective for the treatment or prevention of COVID-19. Misbranded or unapproved new drugs are subject to detention and refusal of admission, if they are offered for importation into the United States. The list of firms that have received warning letters is located here.
FDA issued Emergency Use Authorizations (EUAs) for the following SARS-CoV-2 molecular diagnostic tests:?
Media Contact:[email protected], 240-402-6386 Consumer Inquiries: 888-INFO-FDA
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
Ironwood Pharmaceuticals, Inc. today announced that management will participate in a fireside chat at The Citizens JMP Life Sciences Conference on Monday, May 13, 2024 at 10:00 a.m. ET at the New York Hilton Midtown.
A live audio webcast of...
Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the first quarter ended March 31, 2024, and reiterated full year 2024 financial guidance.
"Vertex delivered a strong start to 2024 with 13 percent product...
Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on May 1, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...
Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today reported financial results for its fiscal second quarter ended March 31, 2024.
"At...
FIS® , a global leader in financial technology, today reported its first quarter 2024 results.
"We are off to a very strong start in 2024. This marks the fifth straight quarter of exceeding our financial outlook, and we are pleased with the...
Lattice Semiconductor , the low power programmable leader, today announced its Lattice Sentrytm solution stack has been named a Global InfoSec Award 2024 winner in the Next Gen Endpoint Security category by Cyber Defense Magazine (CDM) for enabling...